Floatz logo

Therapeutic Asset Ratings

7,021 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Monomethyl Fumarate
Recurrent Adult Burkitt Lymphoma
Masonic Cancer Center, University of MinnesotaP3BB (70)
Monomethyl Fumarate
Recurrent Adult Diffuse Large Cell Lymphoma
Fred Hutchinson Cancer CenterP3BB (70)
Montanide Isa 51
Acute Myelogenous Leukemia (AML)
Sellas Life Sciences GroupP3BB (70)
N-Acetyl-L-Cysteine
Pulmonary Fibrosis
Boehringer IngelheimP3BB (70)
NILUTAMIDE
Prostate Adenocarcinoma
SWOG Cancer Research NetworkP3BB (70)
Nivolumab
Lung Adenocarcinoma
Emory UniversityP3BB (70)
Nivolumab
Colorectal Neoplasm
Bristol-Myers SquibbP3BB (70)
Nivolumab
Urethra Transitional Cell Carcinoma
Nagoya UniversityP3BB (70)
Nivolumab
Colon Adenocarcinoma
IFOM ETS - The AIRC Institute of Molecular OncologyP3BB (70)
nrt6003
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical UniversityP3BB (70)
Ocrevus
Non-Active SPMS
Indapta Therapeutics, INC.P3BB (70)
Olaparib
Hereditary Breast Ovarian Cancer Syndrome
VA Office of Research and DevelopmentP3BB (70)
Olaparib
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P3BB (70)
Olaparib
Ovarian Endometrioid Adenocarcinoma
University of Colorado, DenverP3BB (70)
Olaparib
Ovarian Serous Adenocarcinoma
Institute of Cancer Research, United KingdomP3BB (70)
Olaparib
Primary Peritoneal Serous Adenocarcinoma
NRG OncologyP3BB (70)
Olaparib
Recurrent Ovarian Endometrioid Adenocarcinoma
University of Colorado, DenverP3BB (70)
Olaparib
Primary Peritoneal Carcinoma
University of Colorado, DenverP3BB (70)
Omaveloxolone
Friedreich Ataxia
BiogenP3BB (70)
Opnurasib
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP3BB (70)
Orelabrutinib
Primary Central Nervous System Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP3BB (70)
Osimertinib
EGFR Activating Mutation
Tianjin Medical University Cancer Institute and HospitalP3BB (70)
Palbociclib
Estrogen-Receptor Positive Breast Cancer
Forward Pharmaceuticals Co., Ltd.P3BB (70)
Palonosetron
Nausea and Vomiting
Jiuda ZhaoP3BB (70)
PEGASPARGASE
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)P3BB (70)
Showing 551 to 575 of 7,021 assets
PreviousPage 23 of 281Next